APS Type 1 (Autoimmune Polyglandular Syndrome Type 1) also known as Autoimmune Polyendocrinopathy Syndrome Type 1, is a rare, inherited disease characterized by immune-cell dysfunction with multiple autoimmunities. Caused by a mutated gene, this disorder presents in childhood, is chronic and has the potential to be life threatening.
Because the disorder is rare, occurring in as few as one out of every two to three million people in the U.S., and has symptoms that are common with other disorders, diagnosing the disease can be difficult.
To help support the APS Type 1 community, share cutting-edge research and raise awareness, the Second International Symposium on APS Type 1 will be held July 13 through July 15 at the Charles B. Wang Center. A reception is scheduled for the evening of Thursday, July 13, with working sessions taking place on Friday and Saturday. Dr. Margaret M. McGovern, professor and chair, Department of Pediatrics, Stony Brook University School of Medicine, is helping to support the event.
Among esteemed speakers from Europe and North America are Dr. Anupama Chawla, director of Pediatric Gastroenterology and Nutrition at Stony Brook Children’s Hospital, and Dr. Andrew Lane, director of the Pediatric Endocrinology Fellowship Program and professor of Clinical Pediatrics in the Division of Pediatric Endocrinology, Department of Pediatrics, Stony Brook University School of Medicine.
Families, patients, caregivers, physicians, researchers and interested community members are urged to attend. Children are welcome. This important event will give attendees the opportunity to learn about the latest science around APS Type 1, gain a better understanding of the condition as well as the challenges it presents, and start building a support system.
There is no registration fee. For more information, a full list of presenters, complete agenda and to register please visit the symposium website.